First National Bank Of South Miami Gilead Sciences, Inc. Transaction History
First National Bank Of South Miami
- $124 Million
- Q2 2023
A detailed history of First National Bank Of South Miami transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, First National Bank Of South Miami holds 3,134 shares of GILD stock, worth $349,535. This represents 0.19% of its overall portfolio holdings.
Number of Shares
3,134
Previous 3,164
0.95%
Holding current value
$349,535
Previous $262,000
8.02%
% of portfolio
0.19%
Previous 0.21%
Shares
19 transactions
Others Institutions Holding GILD
# of Institutions
2,092Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.9 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$8 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.73 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.46 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $140B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...